Primary Site >> Colorectal Cancer
Gene >> RTN4R
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Improved biological activity of a mutant endostatin containing a single amino-acid substitution. PMID: 15083196 |
Ref: Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. PMID: 17893520 |
Ref: Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours. PMID: 19900802 Ref: Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy. PMID: 20708923 |
Ref: Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies. PMID: 20855468 |
Ref: Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain. PMID: 22221736 Ref: MUC5AC/beta-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors. PMID: 23112547 |
Ref: Cerenkov luminescence tomography of aminopeptidase N (APN/CD13) expression in mice bearing HT1080 tumors. PMID: 23490443 |
Ref: Antitumor activity of iNGR-GRIM-19 in colorectal cancer. PMID: 28903530 |